A Safety, Tolerability, and Pharmacokinetics Study of MLN0128 as a Single Agent and in Combination With Paclitaxel in Adults With Advanced Nonhematologic Malignancies
Clinical trial NCT02412722 · COMPLETED
Trial details
- NCT number
- NCT02412722
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-26
- Primary completion
- 2018-05-31
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.